Champions Oncology Inc expected to post earnings of 3  cents a share - Earnings Preview

Champions Oncology

11/03/2022 21:44

* Champions Oncology Inc  CSBR.OQ   CSBR.O  is expected
to show a
rise in quarterly revenue when it reports  results on March 11. 
    * The Baltimore Maryland-based  company is expected to
report  a
15.3% increase in revenue to $12.468 million from $10.81 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Champions Oncology
Inc is
for earnings of 3 cents per share. For the same quarter last
year, the company reported earnings of 5 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Champions
Oncology Inc is $16​, above​ its last closing price of $8.17.
​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Oct. 31 2021  0.01        0.01       0.02      Beat    300
 Jul. 31 2021  0.01        0.01       -0.01     Missed  -200
 Apr. 30 2021  0.00        0.00       -0.04     Missed  ​
 Jan. 31 2021  0.00        0.01       0.05      Beat    649.6
 ​​Oct.        0.00        0.00       0.00      Met     
 31 2020                                                
 Jul. 31 2020  0.02        0.02       0.01      Missed  -50​
 Apr. 30 2020              0.02       -0.14     Missed  -1,033
                                                        .3
 Jan. 31 2020  0.03        0.03       0.03      Met     12.5
 This summary was machine generated March 11 at 21:44 GMT.  All
figures in US dollars  unless otherwise stated